Tech Company Financing Transactions

FoldRx Pharmaceuticals Funding Round

FoldRx Pharmaceuticals, based in Cambridge, secured $32.3 million in investment from Alta Partners, F-Prime Capital and HealthCare Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

100 Acorn Park Drive 5th Floor
Cambridge, MA 02140
USA

Phone

(617) 252-5500

Website

www.foldrx.com

Email Address

[email protected]

Overview

FoldRx is a leader in the discovery and development of first in class disease modifying drug therapies for diseases of protein misfolding and amyloidosis.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Richard Labaudiniere

        

Chief Medical Officer

Donna Grogan

        

Vice President

Bill Aliski

        

Vice President

Jeff Packman

        

Browse more venture capital transactions:

Prev: 3/31/2007: AuthenTec venture capital transaction
Next: 3/31/2007: ReGen Biologics venture capital transaction

Share this article

Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary